IPOPLUS

2,334.9

-42.9 -1.80%

18 Jun 2026

NSE Listed · Pharmaceuticals

Caplin Point Lab Ltd. (CAPLIPOINT)

Volume: 5,390Avg Vol 1W: 55,440Avg Vol 1M: 1,50,19952W Range:1,500.32,447.3
₹2,334.9 1.80%
Market Cap₹18,329 Cr
Current Price₹2,334.9
Previous Close₹2,377.8
High / Low (52w)₹2,447.3 / ₹1,500.3
Volume5,390
Avg Vol (1W)55,440
Avg Vol (1M)1,50,199
Stock P/E28.38
Book Value₹471.9
Dividend Yield0.17%
ROE17.88%
ROA16.06%
Revenue (TTM)
Revenue Growth14.37%
Profit Margin29.32%
Total Debt₹0 Cr
Shares Outstanding8 Cr
Face Value₹2
EPS (TTM)₹22.38
P/B5.01
Debt / Equity0
50 DMA₹2,066.72
200 DMA₹1,802.24
Day change-1.80%
Price Chart
2,334.9 16.10% · 1Y
2411150522.7L
2025-10-20
2026-06-16

20-day avg volume: 1.6L shares

Pros
  • Healthy return on equity of 17.9%.
  • Company is almost debt-free.
  • Revenue grew 15% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹600 Cr₹543 Cr₹534 Cr₹510 Cr₹502 Cr₹493 Cr₹483 Cr₹459 Cr₹453 Cr₹436 Cr₹410 Cr₹395 Cr₹389 Cr₹372 Cr₹359 Cr₹346 Cr₹339 Cr₹326 Cr₹304 Cr₹300 Cr₹279 Cr₹274 Cr₹268 Cr₹240 Cr₹215 Cr
EBITDA₹214 Cr₹204 Cr₹201 Cr₹185 Cr₹177 Cr₹177 Cr₹169 Cr₹154 Cr₹146 Cr₹146 Cr₹146 Cr₹127 Cr₹124 Cr₹112 Cr₹111 Cr₹105 Cr₹100 Cr₹99 Cr₹98 Cr₹90 Cr₹85 Cr₹80 Cr₹80 Cr₹69 Cr₹65 Cr
Net Profit₹170 Cr₹164 Cr₹154 Cr₹153 Cr₹143 Cr₹139 Cr₹131 Cr₹124 Cr₹122 Cr₹117 Cr₹115 Cr₹103 Cr₹102 Cr₹97 Cr₹92 Cr₹85 Cr₹79 Cr₹75 Cr₹75 Cr₹71 Cr₹66 Cr₹64 Cr₹57 Cr₹55 Cr₹49 Cr
EPS22.3121.5120.2520.0318.6918.1917.1216.2415.915.3915.0613.5513.3312.7511.9911.1210.339.819.869.258.648.467.467.156.41
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹2,034 Cr₹1,761 Cr₹1,523 Cr₹1,308 Cr₹1,085 Cr₹905 Cr
EBITDA₹677 Cr₹565 Cr₹452 Cr₹387 Cr₹315 Cr₹270 Cr
Net Profit₹536 Cr₹457 Cr₹376 Cr₹300 Cr₹242 Cr₹215 Cr
EPS70.2559.949.1839.2631.7128.2
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹3,208 Cr₹2,698 Cr₹2,191 Cr₹1,736 Cr₹1,364 Cr₹1,126 Cr
Total Liabilities₹321 Cr₹351 Cr₹284 Cr₹226 Cr₹160 Cr₹169 Cr
Equity₹2,886 Cr₹2,347 Cr₹1,907 Cr₹1,510 Cr₹1,203 Cr₹957 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹560 Cr₹427 Cr₹359 Cr₹418 Cr₹335 Cr₹99 Cr
Investing₹-335 Cr₹-320 Cr₹-218 Cr₹-377 Cr₹-29 Cr₹-55 Cr
Financing₹-38 Cr₹-38 Cr₹-28 Cr₹-41 Cr₹-24 Cr₹80 Cr
Free Cash Flow₹560 Cr₹427 Cr₹359 Cr₹418 Cr₹335 Cr₹99 Cr
Shareholding
Promoter 70.57% Institutions 8.29% Public 21.14%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search